Determination of Gentamicin Dosing in Neonatal Patients
NCT ID: NCT00198601
Last Updated: 2018-04-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
INTERVENTIONAL
2003-08-31
2005-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Once Daily Versus 8 Hour Dosing of Gentamicin for the Treatment of Intrapartum Chorioamnionitis
NCT00185991
Selective Use of Antibiotics in Neonates Born to Mothers With Suspected Chorioamnionitis
NCT03576560
Vitality in Infants Via Azithromycin for Neonates Trial
NCT05763693
Prevention of Bacterial Infections in Newborn
NCT01800942
Diagnostic Performance Comparison Between Procalcitonin-based vs. ANAES-based Guidelines
NCT02590198
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gentamicin in Uniject Pre-filled syringe
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* infants 2000-2499 at birth
* infants \> 2500 gm at birth
* infants \< 2000 gm at birth
* in study site areas: Pakistan, Bangladesh and India
Exclusion Criteria
1 Minute
28 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johns Hopkins Bloomberg School of Public Health
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gary Darmstadt, MD
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins Bloomberg School of Public Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dhaka Shishu Hospital
Dhaka, , Bangladesh
Neonatal Intensive Care Unit - Christian Vellore Medical
Vellore, , India
Aga Khan
Karachi, , Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H.22.02.08.30.B1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.